Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Durogesic D-Trans for Chronic Non-Cancer Pain
NCT01902524Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Oct 2005
- Primary completion
- Nov 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fentanyl in chronic pain, sponsored by Janssen Pharmaceutical. Primary endpoint: The change in pain intensity at 12 weeks. Started Oct 2005; status: completed.
02
Drugs
fentanyl
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT01902524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01902524.